Crewe Advisors LLC Perkinelmer Inc Transaction History

Crewe Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$118.07 - $160.96 $42,032 - $57,301	-356 Reduced 88.78%	45 $5,000
Q2 2022 Aug 02, 2022	BUY	$134.91 - $172.49 $45,734 - $58,474	339 Added 546.77%	401 $57,000
Q1 2022 Apr 27, 2022	SELL	$162.31 - $192.2 $1,947 - $2,306	-12 Reduced 16.22%	62 $11,000
Q4 2020 Jan 27, 2021	BUY	$122.05 - $147.91 $3,661 - $4,437	30 Added 68.18%	74 $11,000
Q2 2020 Jul 24, 2020	BUY	$70.83 - $105.31 $3,116 - $4,633	44 New	44 $4,000

574

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.